Teva Pharmaceuticals USA, Inc recalls GSMS Incorporated — Losartan Potassium 25 mg and 100 mg Tablets USP
- Recall date
- April 26, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Teva Pharmaceuticals USA, Inc, GSMS Incorporated
Why it was recalled
Due to The Detection of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) — Unapproved Ingredient
What was recalled
Losartan Potassium 25 mg and 100 mg Tablets USP
Read the official recall notice →
Get recall alerts
Free email alert whenever Teva Pharmaceuticals USA, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Teva Pharmaceuticals USA, Inc, GSMS Incorporated